Tetrahydroisoquinololine derivatives as modulators of dopamine D₃ receptors

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 985-989

Informa Healthcare

Access to resources Recommend Favorite

The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

By Wicke K.   Garcia-Ladona J.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

Modification of dopamine D 1 receptor knockout phenotype in mice lacking both dopamine D 1 and D 3 receptors

By Karasinska J.M.   George S.R.   El-Ghundi M.   Fletcher P.J.   O'Dowd B.F.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 171-181

Elsevier

Access to resources Recommend Favorite

Relative affinities of dopaminergic drugs at dopamine D 2 and D 3 receptors

By Levant B.   Grigoriadis D.E.   De Souza E.B.  

European Journal of Pharmacology, Vol. 278, Iss. 3, 1995-05 ,pp. : 243-247

Elsevier

Access to resources Recommend Favorite

Half a century of antipsychotics and still a central role for dopamine D 2 receptors

By Kapur S.   Mamo D.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 7, 2003-10 ,pp. : 1081-1090

Elsevier

Access to resources Recommend Favorite